[International] [Peer Reviewed] 

About OAMJMS

Our policies

OAMJMS Online

For contributors

Services

Why publish in OAMJMS?
Editors
Boards
Publication fee
Indexing
Membership
Evaluation

Editorial & publishing policies
Competing interests policy 
Open access
Open access license

Reviewer guidelines
CrossCheck Plagiarism Screening
CrossMark Policy Page

Online first
Current issue
Journal archive

Online first fact sheet
Free Registration
Contact
Webmail

Guidelines  [pdf]
Online submission MC
Online submission OJS
Help for authors
Cover letter
Reviewers of OAMJMS

Reviewer Summary

Transliteration
Subscriptions

Sponsors
Reprints and permissions
Resources
ICMJE Disclosure Form

OTHER SOURCES: | Official Website | PubMed Central | Europe PMC | PMC Canada | PubMed | DOAJ | De Gruyter | Former MJMS |

 

ID Design 2012/DOOEL Skopje, Republic of Macedonia

Open Access Macedonian Journal of Medical Sciences.

https://doi.org/10.3889/oamjms.2017.098

eISSN: 1857-9655

Letter to the Editor

 

 

 

Congenital Progressive Mutilating Hemangioma


 

Anastasiya Chokoeva1, Radica Sokolova2, Torello Lotti3, Uwe Wollina4, Serena Gianfaldoni4, Jacopo Lotti5, Katlein França6 Georgi Tchernev1,7*

 

1”Onkoderma” - Policlinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria; 2Department of Dermatology and Venereology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria; 3University of Rome, “G. Marconi”, Rome, Italy; 4Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, 01067 Dresden, Germany; 5Department of Nuclear, Subnuclear and Radiation Physics, University of Rome "G. Marconi", Rome, Italy; 6Institute for Bioethics & Health Policy; Department of Dermatology & Cutaneous Surgery; Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine - Miami, FL, USA; 7Medical Institute of Ministry of Interior (MVR-Sofia), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia, Bulgaria

 

Abstract

 

 

A 73-year-old male patient was admitted with symptoms of decompensated cardiac and pulmonary insufficiency with long-lasting history. A tumor-like formation was observed within the clinical examination, covering the whole skin of the nose, paranasal region of the left part of the face, as well as the upper and lower left eyelids. The lesion was with yellow to brownish surface and dark-reddish to violet discolored peripheral area, composed of nodular formations, smooth central surface and firm texture on palpation. The histopathological examination verified the diagnosis of hemangioma, which had been congenital, regarding the patient’s history, treated surgically about 50 years ago, with signs of recurrence. The presented patient had been treated surgically at the age of 20, without medical evidence of the type of the performed excision. The recurrence occurs almost 50 years later, at the age of 78. To the best of our knowledge, this is the first reported recurrence of infantile hemangioma, treated surgically almost 50 years ago.

 

..................

Citation: Chokoeva A, Sokolova R, Lotti T, Wollina U, Gianfaldoni S, Lotti J, França K, Tchernev G. Congenital Progressive Mutilating Hemangioma. Open Access Maced J Med Sci. https://doi.org/10.3889/oamjms.2017.098
Keywords: infantile hemangioma; plastic surgery; mutilation; beta blockers; topicall approach.
*Correspondence: Prof. Dr. Georgi Tchernev. Specialist for Dermatology, Venereology and Dermatologic surgery. ”Onkoderma”- Policlinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria; Medical Institute of Ministry of Interior (MVR-Sofia), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia, Bulgaria. E-mail: georgi_tchernev@yahoo.de
Received: 09-May-2017; Revised: 18-May-2017; Accepted: 19-May-2017; Online first: 11-Jun-2017
Copyright: © 2017 Anastasiya Chokoeva, Radica Sokolova, Torello Lotti, Uwe Wollina, Serena Gianfaldoni, Jacopo Lotti, Katlein França, Georgi Tchernev. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
Funding: This research did not receive any financial support.
Competing Interests: Publication of this paper has been supported by Roche Macedonia DOOEL Skopje.
 

 

< Previous | Next Article >

Table of contents

 

This Article (free)

Full text (pdf)

Full text OnlineFirst (pdf)


Google Scholar

- Chokoeva A
- Sokolova R
- Lotti T
- Wollina U
- Gianfaldoni S
- Lotti J
- França K
- Tchernev G


PubMed

- Chokoeva A
- Sokolova R
- Lotti T
- Wollina U
- Gianfaldoni S
- Lotti J
- França K
- Tchernev G

 

Altmetric
 

 


Published by: Id Design 2012/DOOEL Skopje, Republic of Macedonia


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.